UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Sodium-Glucose Cotransporter-2 Inhibitors
Situation
The sodium-glucose cotransporter-2 inhibitors class review and formulary standardization was evaluated at the May 2020 System Pharmacy and Therapeutics Committee meeting.
Background
The following medications were reviewed: canagliflozin, dapagliflozin, empagliflozin, ertugliflozin
Assessment/Recommendation
Changes effective: Tuesday September 1, 2020
System P&T voted to include the following products on the UNC Health Medication Formulary:
- Empagliflozin
Note: Stock of these products may vary at individual entities
As a result, the following products will be removed from the UNC Health Medication Formulary:
- Canagliflozin
- Dapagliflozin
- Ertugliflozin
- Combination products containing sodium-glucose cotransporter-2 inhibitors